Ignite Creation Date:
2024-05-05 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00393250
Status:
COMPLETED
Last Update Posted:
2021-10-29
First Post:
2006-10-26
Brief Title:
Hypnosis to Manage Pain and Symptoms in Patients With Sickle Cell Disease
Sponsor:
National Institutes of Health Clinical Center CC
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
Hypnosis as a Pain and Symptom Management Strategy in Patients With Sickle Cell Disease
Status:
COMPLETED
Status Verified Date:
2021-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will examine whether hypnosis can reduce the frequency and intensity of pain in patients with sickle cell disease
Patients 18 years of age and older with sickle cell disease and a history of pain associated with their disease may be eligible for this study
Participants are interviewed to assess their frequency and intensity of pain sleep quality coping strategies mood and anxiety and are then randomly assigned to study Group A or B see below All participants are given pain diaries to complete at home and turn in at each clinic visit They undergo the following procedures
Group A
Weeks 1-4 Receive weekly 60-minute hypnosis sessions in which they are given suggestions for relieving pain reducing anxiety improving sleep and enhancing their health and well-being The sessions are audio- and videotaped
Week 5 Are interviewed to assess pain sleep coping strategies mood and anxiety
Week 6 Receive a DVD player and DVD with instruction on how to perform self-hypnosis They practice hypnosis at home as often as needed but at least once a day They record in a pain diary in the morning and the evening their amount of pain medication use school or work attendance quality and amount of sleep and number of times they use self-hypnosis
Weeks 8 10 and 12 Turn in their pain diaries and have a pain assessment
Week 12 Are assessed for how they respond to the hypnosis
Group B
Weeks 1-4 Receive weekly 60-minute sessions of education about sickle cell disease
Week 5 Are interviewed to assess pain sleep coping strategies mood and anxiety
Week 6 Turn in their daily pain diaries and receive a DVD player and DVD that contains educational materials about sickle cell disease
Weeks 8 10 and 12 Turn in their pain diaries and have a pain assessment
Weeks 13-24 Follow the procedures described in weeks 1-12 for Group A
Patients 18 years of age and older with sickle cell disease and a history of pain associated with their disease may be eligible for this study
Participants are interviewed to assess their frequency and intensity of pain sleep quality coping strategies mood and anxiety and are then randomly assigned to study Group A or B see below All participants are given pain diaries to complete at home and turn in at each clinic visit They undergo the following procedures
Group A
Weeks 1-4 Receive weekly 60-minute hypnosis sessions in which they are given suggestions for relieving pain reducing anxiety improving sleep and enhancing their health and well-being The sessions are audio- and videotaped
Week 5 Are interviewed to assess pain sleep coping strategies mood and anxiety
Week 6 Receive a DVD player and DVD with instruction on how to perform self-hypnosis They practice hypnosis at home as often as needed but at least once a day They record in a pain diary in the morning and the evening their amount of pain medication use school or work attendance quality and amount of sleep and number of times they use self-hypnosis
Weeks 8 10 and 12 Turn in their pain diaries and have a pain assessment
Week 12 Are assessed for how they respond to the hypnosis
Group B
Weeks 1-4 Receive weekly 60-minute sessions of education about sickle cell disease
Week 5 Are interviewed to assess pain sleep coping strategies mood and anxiety
Week 6 Turn in their daily pain diaries and receive a DVD player and DVD that contains educational materials about sickle cell disease
Weeks 8 10 and 12 Turn in their pain diaries and have a pain assessment
Weeks 13-24 Follow the procedures described in weeks 1-12 for Group A
Detailed Description:
Sickle cell disease SCD is the most common genetic disease in African-Americans characterized by recurrent painful vaso-occlusive crises Standard medical therapies for controlling or preventing crises are limited because of efficacy andor toxicity Published studies focus on the frequency of acute pain crises resulting in emergency department use and a number of hospitalizations However few studies focus on pain manifestations outside the typical healthcare delivery system Furthermore the proportion of patients who are able to self-manage their crises at home without accessing healthcare professionals is unknown Adjunctive approaches using psychosocial interventions may be effective in further reducing andor preventing painful crises as well as in improving quality of life and reducing health care utilization Recent evidence suggests that learning a cognitive-behavioral intervention centered on self-hypnosis for pain management may be helpful in modulating pain frequency improving sleep quality and decreasing use of narcotic pain medications in patients with SCD
This protocol describes a randomized controlled single-crossover single-blinded pilot study trial of hypnosis for managing pain in SCD patients Subjects receive hypnosis experimental intervention during 4 weeks of face-to-face encounters with a physician trained in hypnosis For 6 weeks following the instruction period the participants will perform daily self-hypnosis using customizable digital media Subjects in the control arm of the study will receive face-to-face education regarding sickle cell disease for the same length and frequency as the treatment group hypnosis encounters before crossing over to the experimental intervention arm of the study Primary outcome measures include patient assessments of pain frequency intensity and quality Secondary outcome measures include face-to face assessments of psychosocial variables including anxiety coping strategies sleep depression and health-care utilization
This protocol describes a randomized controlled single-crossover single-blinded pilot study trial of hypnosis for managing pain in SCD patients Subjects receive hypnosis experimental intervention during 4 weeks of face-to-face encounters with a physician trained in hypnosis For 6 weeks following the instruction period the participants will perform daily self-hypnosis using customizable digital media Subjects in the control arm of the study will receive face-to-face education regarding sickle cell disease for the same length and frequency as the treatment group hypnosis encounters before crossing over to the experimental intervention arm of the study Primary outcome measures include patient assessments of pain frequency intensity and quality Secondary outcome measures include face-to face assessments of psychosocial variables including anxiety coping strategies sleep depression and health-care utilization
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 07-CC-0011 | None | None | None |